Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Obesity 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Inflammation 1 Hodgkin Disease 1 Chemotherapy Effect 1

Interventions

palbociclib 1 microcrystalline cellulose 1 epigallocatechin gallate 1 dapagliflozin 1 Vitamin D 1 Tablets 1 Specimen Handling 1 Selenium 1 Saline Solution 1 Pregabalin 1 Platelet Count 1 Plastic Surgery Procedures 1 Omeprazole 1 Losartan 1 Ketorolac 1 Infliximab 1 Immunotherapy, Adoptive 1 Dexmedetomidine 1 Cognitive Behavioral Therapy 1 Calcium 1 Bevacizumab 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Inflammation × Omeprazole × Clear all

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡